Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Paxillin Antikörper (pTyr88)

Der Kaninchen-Polyklonal Anti-Paxillin-Antikörper wurde für WB, ELISA und IF validiert. Er ist geeignet zum Nachweis von Paxillin in Proben aus Human. }
Produktnummer ABIN7139085
-15% Promotion 2026
336,60 €
396,00 €
Sparen Sie 59,40 € (-15 %)
Zzgl. Versandkosten 20,00 € und MwSt
100 μL
Lieferung nach: Deutschland
Lieferung in 11 bis 15 Werktagen

Kurzübersicht für Paxillin Antikörper (pTyr88) (ABIN7139085)

Target

Alle Paxillin (PXN) Antikörper anzeigen
Paxillin (PXN)

Reaktivität

  • 246
  • 138
  • 106
  • 17
  • 8
  • 7
  • 6
  • 5
  • 4
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
Human

Wirt

  • 239
  • 26
  • 1
Kaninchen

Klonalität

  • 189
  • 77
Polyklonal

Konjugat

  • 130
  • 13
  • 9
  • 9
  • 9
  • 9
  • 9
  • 9
  • 6
  • 6
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
Dieser Paxillin Antikörper ist unkonjugiert

Applikation

  • 199
  • 73
  • 66
  • 44
  • 41
  • 40
  • 32
  • 31
  • 25
  • 19
  • 14
  • 7
  • 2
  • 2
  • 1
  • 1
  • 1
Western Blotting (WB), ELISA, Immunofluorescence (IF)
  • Bindungsspezifität

    • 34
    • 33
    • 23
    • 16
    • 10
    • 10
    • 9
    • 6
    • 6
    • 6
    • 5
    • 4
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    pTyr88

    Verwendungszweck

    Phospho-PXN (Tyr88) Antibody

    Aufreinigung

    Antibodies were produced by immunizing rabbits with synthetic phosphopeptide and KLH conjugates. Antibodies were purified by affinity-chromatography using epitope-specific phosphopeptide. Non-phospho specific antibodies were removed by chromatogramphy usi

    Immunogen

    Peptide sequence around phosphorylation site of tyrosine 88 (P-V-Y(p)-G-S) derived from Human Paxillin.

    Isotyp

    IgG
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Buffer

    Supplied at 1.0 mg/mL in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    -20 °C,-80 °C

    Informationen zur Lagerung

    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target

    Paxillin (PXN)

    Andere Bezeichnung

    PXN

    Hintergrund

    Background: An antiphosphotyrosine antibody was used to identify proteins that are phosphorylated in Rous sarcoma virus-transformed chick embryo fibroblasts, and a 76-kD protein was obtained that localizes to focal adhesions at the ends of actin-containing stress fibers in nontransformed cells (Ref.1). This protein was purified from chicken gizzard smooth muscle, and was named Pxn (Paxillin) ('paxillus' means 'small stake' or 'peg' in Latin) as a protein tethered to the membrane at focal adhesions

    Turner, C.E. (2000) J. Cell Sci. 113, 4139-4140
    Burridge, K. et al. (1992) J. Cell Biol. 119, 893-903.
    Bellis, S. L. et al. (1997) Biochem. J. 325, 375-381.

    Aliases: FLJ16691 antibody, FLJ23042 antibody, Paired box protein Pax 1 antibody, PAX 1 antibody, PAX1 antibody, PAXI_HUMAN antibody, Paxillin alpha antibody, Paxillin antibody, PXN antibody, PXN protein antibody

    UniProt

    P49023

    Pathways

    MAPK Signalweg, EGFR Signaling Pathway, Response to Growth Hormone Stimulus, Cell-Cell Junction Organization, Maintenance of Protein Location, CXCR4-mediated Signaling Events, Signaling Events mediated by VEGFR1 and VEGFR2, Signaling of Hepatocyte Growth Factor Receptor, VEGF Signaling
Sie sind hier:
Chat with us!